Balance Sheet

v3.24.3

Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 9,563	$ 1,173
Prepaid expenses and other current assets	468	192
Deferred offering costs		101
Total assets	10,031	1,466
Current liabilities:
Accounts payable	686	561
Accrued expenses	1,086	614
Total current liabilities	1,772	1,175
Common stock warrant liability	1,188	3,291
Total liabilities	2,960	4,466
Commitments and contingencies (Note 5)
Stockholders’ equity (deficit):
Convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized as of September 30, 2024, and December 31, 2023, respectively; no shares issued and outstanding at September 30, 2024, and December 31, 2023
Common stock, $0.0001 par value, 250,000,000 shares authorized at September 30, 2024, and December 31, 2023; 24,001,339 and 10,693,580 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively	2	1
Additional paid-in capital	54,410	38,404
Accumulated deficit	(47,341)	(41,405)
Total stockholders’ equity (deficit)	7,071	(3,000)
Total liabilities and stockholders’ equity (deficit)	$ 10,031	$ 1,466

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source

Delivering Therapy Where it Matters

Quicklinks

Delivering Therapy Where it Matters

Quicklinks